FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss

FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss

The risk appears small and data is mixed, but FDA wants patients to be aware.

arstechnica.com/health/2026/11/glp-1-drugs-may-increase-risk-of-vision-loss-from-rare-condition-fda-warns/